We are live on ! Find out more
Cliff Asness

Cliff Asness AQR Capital Management

AUM $337B Turnover 9.09%
1-Year Est. Return 36.06%
 

Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.

This Fund
S&P 500
This Quarter Est. Return
+1.59%
1 Year Est. Return
+36.06%
3 Year Est. Return
+133.13%
5 Year Est. Return
+158.29%
10 Year Est. Return
+535.66%
AUM
$36.4B
AUM Growth
-$720M
Cap. Flow
-$2.61B
Cap. Flow %
-7.17%
Top 10 Hldgs %
9.35%
Holding
2,708
New
200
Increased
858
Reduced
1,062
Closed
203
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
0.5 years
Top 20 Avg Time Held Equity + Options
0.7 years
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.7 years

Top Buys

Rank Stock Value
1
SHPG
Shire
SHPG
+$147M
2
GILD icon
Gilead Sciences
GILD
+$127M
3
INTC icon
Intel
INTC
+$114M
4
LO
Lorillard
LO
+$113M
5
TWX
Time Warner
TWX
+$112M

Sector Composition

Rank Sector Weight
1 Healthcare 14.66%
2 Technology 13.5%
3 Miscellaneous 11.61%
4 Energy 10.09%
5 Financials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.08T
$544M 1.5%
21,599,116
+1,815,464
+9% +$44.6M
2013 Q2
5 quarters
JNJ icon
2
Johnson & Johnson
JNJ
$639B
$372M 1.02%
3,490,742
-154,106
-4% -$16M
2013 Q2
5 quarters
BIIB icon
3
Biogen
BIIB
$36.4B
$367M 1.01%
1,107,999
+316,275
+40% +$104M
2013 Q2
5 quarters
GOOG icon
4
Alphabet (Google) Class C
GOOG
$3.53T
$343M 0.94%
11,771,089
+479,553
+4% +$13.9M
2013 Q2
5 quarters
META icon
5
Meta Platforms (Facebook)
META
$1.58T
$329M 0.9%
4,158,402
-127,557
-3% -$9.36M
2013 Q3
4 quarters
PFE icon
6
Pfizer
PFE
$157B
$309M 0.85%
11,019,973
+63,330
+0.6% +$1.78M
2013 Q2
5 quarters
MSFT icon
7
Microsoft
MSFT
$3.85T
$297M 0.82%
6,415,622
+148,413
+2% +$6.62M
2013 Q2
5 quarters
WFC icon
8
Wells Fargo
WFC
$243B
$292M 0.8%
5,628,140
-167,788
-3% -$8.63M
2013 Q2
5 quarters
ADM icon
9
Archer Daniels Midland
ADM
$31.9B
$287M 0.79%
5,615,112
+446,124
+9% +$21.9M
2013 Q2
5 quarters
INTC icon
10
Intel
INTC
$301B
$264M 0.72%
7,568,138
+3,381,500
+81% +$114M
2013 Q2
5 quarters
MRK icon
11
Merck
MRK
$330B
$262M 0.72%
4,634,669
+1,068,661
+30% +$60M
2013 Q2
5 quarters
XOM icon
12
ExxonMobil
XOM
$651B
$254M 0.7%
2,698,942
-50,592
-2% -$5.04M
2013 Q2
5 quarters
CVS icon
13
CVS Health
CVS
$102B
$250M 0.69%
3,142,064
+97,088
+3% +$7.65M
2013 Q2
5 quarters
WDC icon
14
Western Digital
WDC
$114B
$249M 0.68%
3,379,348
-675,175
-17% -$50.7M
2013 Q2
5 quarters
PSX icon
15
Phillips 66
PSX
$94.8B
$245M 0.67%
3,015,130
+588,454
+24% +$49M
2013 Q2
5 quarters
GILD icon
16
Gilead Sciences
GILD
$205B
$241M 0.66%
2,261,483
+1,292,298
+133% +$127M
2013 Q2
5 quarters
ELV icon
17
Elevance Health
ELV
$83.7B
$237M 0.65%
1,978,797
+32,158
+2% +$3.69M
2013 Q2
5 quarters
HUM icon
18
Humana
HUM
$45.4B
$236M 0.65%
1,813,453
+36,064
+2% +$4.58M
2013 Q2
5 quarters
NOC icon
19
Northrop Grumman
NOC
$76.6B
$233M 0.64%
1,772,153
-21,365
-1% -$2.7M
2013 Q2
5 quarters
EOG icon
20
EOG Resources
EOG
$77.2B
$229M 0.63%
2,309,658
+36,314
+2% +$3.95M
2013 Q2
5 quarters
TWC
21
DELISTED
Time Warner Cable
TWC
$228M 0.63%
1,592,319
-357,442
-18% -$53.1M
2013 Q2
5 quarters
TSN icon
22
Tyson Foods
TSN
$21.8B
$212M 0.58%
5,380,835
+232,477
+5% +$8.89M
2013 Q2
5 quarters
SHPG
23
DELISTED
Shire
SHPG
$211M 0.58%
816,116
+592,164
+264% +$147M
2014 Q2
1 quarter
MCK icon
24
McKesson
MCK
$121B
$210M 0.58%
1,076,885
-175,148
-14% -$33.7M
2013 Q2
5 quarters
HAL icon
25
Halliburton
HAL
$26.3B
$209M 0.57%
3,238,462
+493,368
+18% +$33.8M
2013 Q2
5 quarters

Similar funds

Cliff Asness's Q3 2014 Portfolio in Review

As of Q3 2014, Cliff Asness held 2,708 positions worth $36.4B, down 1.9% from $37.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Cliff Asness withdrew a net $2.61B in Q3 2014, closing 203 positions and reducing 1,062 holdings. Its most notable exit was Forest Laboratories, an estimated $243M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Cliff Asness opened a new position in Bally Technologies worth $80.5M.

  • Cliff Asness's largest Q3 2014 buy was Bally Technologies: 997,907 shares worth $80.5M.
  • Cliff Asness added most to Shire in Q3 2014, an estimated $147M increase.
  • Cliff Asness's biggest Q3 2014 reduction was Western Refining, cutting an estimated $148M.
  • Cliff Asness fully exited Forest Laboratories in Q3 2014, selling an estimated $243M.
  • Cliff Asness's ten largest holdings make up 9.4% of its $36.4B portfolio in Q3 2014.
  • Cliff Asness opened 200 new positions and closed 203 in Q3 2014.
  • Cliff Asness's portfolio value fell 1.9% quarter-over-quarter to $36.4B.

Based on AQR Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.